Candesartan 16mg

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Essential HypertensionHypertension

Phase 2

A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

Chong Kun Dang PharmaceuticalEssential Hypertension

Start: 2014-03-31End: 2015-06-30Target: 456Updated: 2015-03-30

Phase 3

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

CompletedNCT02651870

Chong Kun Dang PharmaceuticalHypertension

Start: 2015-04-22End: 2016-02-29Updated: 2020-08-25